"10.1371_journal.pone.0101930","plos one","2014-07-22T00:00:00Z","Aniek Boers; Lorian Slagter-Menkema; Bettien M van Hemel; Jerome L Belinson; Teus Ruitenbeek; Henk J Buikema; Harry Klip; Hilde Ghyssaert; Ate G J van der Zee; Geertruida H de Bock; G Bea A Wisman; Ed Schuuring","Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Preventive Oncology International, Inc, Cleveland Heights and Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, United States of America; Department of Pathology, AZ St Jan Brugge-Oostende, Brugge, Belgium; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands","Conceived and designed the experiments: AB ES. Performed the experiments: LS-M TR HJB HK HG. Analyzed the data: AB JLB GHdB. Contributed reagents/materials/analysis tools: JLB. Wrote the paper: AB BMvH AGJvdZ GHdB GBAW ES.","The authors have read the journals policy and have the following conflicts: Ed Scuuring is a member of the scientific advisory board of Roche, Hologic and QCMD, received travel reimbursements from Roche, Abbott, Hologic Inc. and QCMD. AB, LSM, BvH received travel reimbursements from Hologic Inc. Jerome L. Belinson has received support in kind (reagents and testing) and funds for direct support and research, under the auspices of Preventive Oncology International Inc., from Hologic Inc., Qiagen, Gen-Probe, Merck Inc., BGI Shenzen, and GE Healthcare. The Cervista HPV HR test reagents were kindly provided by Hologic Inc. for this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","07","Aniek Boers","AB",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
